SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-015503
Filing Date
2023-03-31
Accepted
2023-03-31 19:56:04
Documents
1
Period of Report
2023-03-29

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 2786
  Complete submission text file 0001140361-23-015503.txt   4151
Mailing Address C/O TARGACEPT, INC. 200 EAST FIRST STREET, SUITE 300 WINSTON-SALEM NC 27101
Business Address
Jones Elaine V (Reporting) CIK: 0001296907 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 23789960

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations